Work

Knocking off cancer’s HAT: CSS1477 disrupts oncogenic programs

Year: 2023

Type: article

Source: Cell chemical biology

DOI: 10.1016/j.chembiol.2023.11.014

Authors: Luyao Kevin Xu, Panagiotis Ntziachristos

Institutions: Ghent University Hospital, Ghent University, AstraZeneca (United States), Cancer Research Institute Ghent

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: AstraZeneca

OpenAlex ID: W4390065131

FWCI: 0.178

Cites: 11

Cited by: 2

Related to: 10